The ADAPT Study: Use of Emtricitabine and Tenofovir Disoproxil Fumarate for Pre-Exposure Prophylaxis (PrEP)
Clinical trial NCT01327651 · COMPLETED
Trial details
- NCT number
- NCT01327651
- Sponsor
- HIV Prevention Trials Network
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2014-12-01
- Enrollment
- 622
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.